{"id":"https://openalex.org/W34816746","doi":"https://doi.org/10.1182/blood.v89.8.3025","title":"The Potential of Iron Chelators of the Pyridoxal Isonicotinoyl Hydrazone Class as Effective Antiproliferative Agents II: The Mechanism of Action of Ligands Derived From Salicylaldehyde Benzoyl Hydrazone and 2-Hydroxy-1-Naphthylaldehyde Benzoyl Hydrazone","display_name":"The Potential of Iron Chelators of the Pyridoxal Isonicotinoyl Hydrazone Class as Effective Antiproliferative Agents II: The Mechanism of Action of Ligands Derived From Salicylaldehyde Benzoyl Hydrazone and 2-Hydroxy-1-Naphthylaldehyde Benzoyl Hydrazone","alternate_titles":[],"publication_year":1997,"publication_date":"1997-04-15","ids":{"openalex":"https://openalex.org/W34816746","doi":"https://doi.org/10.1182/blood.v89.8.3025","mag":"34816746","pmid":"https://pubmed.ncbi.nlm.nih.gov/9108424"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v89.8.3025","doi":"https://doi.org/10.1182/blood.v89.8.3025","is_oa":true,"landing_page_url":"https://doi.org/10.1182/blood.v89.8.3025","pdf_url":"https://ashpublications.org/blood/article-pdf/89/8/3025/1038548/3025.pdf","source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W34816746"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://ashpublications.org/blood/article-pdf/89/8/3025/1038548/3025.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5061763563","display_name":"Des Raymond Richardson","orcid":"https://orcid.org/0000-0002-5506-3274","observed_orcids":["https://orcid.org/0000-0002-5506-3274","https://orcid.org/0000-0003-0960-6415"]},"institutions":[{"id":"https://openalex.org/I2801824472","display_name":"Jewish General Hospital","ror":"https://ror.org/056jjra10","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801824472","https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4405256057","https://openalex.org/I4405279980"]},{"id":"https://openalex.org/I4405267356","display_name":"Lady Davis Institute for Medical Research","ror":"https://ror.org/02c1np254","country_code":"CA","type":"education","lineage":["https://openalex.org/I2801824472","https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4405256057","https://openalex.org/I4405267356","https://openalex.org/I4405279980"]},{"id":"https://openalex.org/I5023651","display_name":"McGill University","ror":"https://ror.org/01pxwe438","country_code":"CA","type":"education","lineage":["https://openalex.org/I5023651"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"D.R. Richardson","raw_affiliation_strings":["From the Lady Davis Institute for Medical Research of the Sir Mortimer B. Davis-Jewish General Hospital, Montre\u0301al, Que\u0301bec, Canada; and the Department of Medicine, McGill University, Montre\u0301al, Que\u0301bec, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Lady Davis Institute for Medical Research of the Sir Mortimer B. Davis-Jewish General Hospital, Montre\u0301al, Que\u0301bec, Canada; and the Department of Medicine, McGill University, Montre\u0301al, Que\u0301bec, Canada","institution_ids":["https://openalex.org/I2801824472","https://openalex.org/I4405267356","https://openalex.org/I5023651"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5016059603","display_name":"K. Milnes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801824472","display_name":"Jewish General Hospital","ror":"https://ror.org/056jjra10","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801824472","https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4405256057","https://openalex.org/I4405279980"]},{"id":"https://openalex.org/I4405267356","display_name":"Lady Davis Institute for Medical Research","ror":"https://ror.org/02c1np254","country_code":"CA","type":"education","lineage":["https://openalex.org/I2801824472","https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4405256057","https://openalex.org/I4405267356","https://openalex.org/I4405279980"]},{"id":"https://openalex.org/I5023651","display_name":"McGill University","ror":"https://ror.org/01pxwe438","country_code":"CA","type":"education","lineage":["https://openalex.org/I5023651"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"K. Milnes","raw_affiliation_strings":["From the Lady Davis Institute for Medical Research of the Sir Mortimer B. Davis-Jewish General Hospital, Montre\u0301al, Que\u0301bec, Canada; and the Department of Medicine, McGill University, Montre\u0301al, Que\u0301bec, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Lady Davis Institute for Medical Research of the Sir Mortimer B. Davis-Jewish General Hospital, Montre\u0301al, Que\u0301bec, Canada; and the Department of Medicine, McGill University, Montre\u0301al, Que\u0301bec, Canada","institution_ids":["https://openalex.org/I2801824472","https://openalex.org/I4405267356","https://openalex.org/I5023651"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":3.719,"has_fulltext":true,"cited_by_count":211,"citation_normalized_percentile":{"value":0.93039573,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":91,"max":99},"biblio":{"volume":"89","issue":"8","first_page":"3025","last_page":"3038"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10452","display_name":"Iron Metabolism and Disorders","score":0.9014000296592712,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10452","display_name":"Iron Metabolism and Disorders","score":0.9014000296592712,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10163","display_name":"Metal complexes synthesis and properties","score":0.052400000393390656,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.007799999788403511,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/iron-chelators","display_name":"iron chelators","score":0.9169999957084656},{"id":"https://openalex.org/keywords/pyridoxal-isonicotinoyl-hydrazone","display_name":"pyridoxal isonicotinoyl hydrazone","score":0.9620000123977661},{"id":"https://openalex.org/keywords/deferoxamine","display_name":"deferoxamine","score":0.8500000238418579},{"id":"https://openalex.org/keywords/antiproliferative-agents","display_name":"antiproliferative agents","score":0.8870000243186951},{"id":"https://openalex.org/keywords/ferritin","display_name":"ferritin","score":0.7680000066757202},{"id":"https://openalex.org/keywords/cell-cycle-arrest","display_name":"cell cycle arrest","score":0.5379999876022339},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.8920000195503235},{"id":"https://openalex.org/keywords/necrosis","display_name":"necrosis","score":0.8809999823570251},{"id":"https://openalex.org/keywords/neuroblastoma","display_name":"neuroblastoma","score":0.5669999718666077}],"concepts":[{"id":"https://openalex.org/C2780349576","wikidata":"https://www.wikidata.org/wiki/Q416007","display_name":"Hydrazone","level":2,"score":0.7737414836883545},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.624640166759491},{"id":"https://openalex.org/C2780859938","wikidata":"https://www.wikidata.org/wiki/Q3065731","display_name":"Pyridoxal","level":3,"score":0.5691317915916443},{"id":"https://openalex.org/C2779256853","wikidata":"https://www.wikidata.org/wiki/Q414492","display_name":"Salicylaldehyde","level":3,"score":0.5450509190559387},{"id":"https://openalex.org/C2776120743","wikidata":"https://www.wikidata.org/wiki/Q3271540","display_name":"Mechanism of action","level":3,"score":0.5333941578865051},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.5298027396202087},{"id":"https://openalex.org/C197404232","wikidata":"https://www.wikidata.org/wiki/Q319827","display_name":"Chelation","level":2,"score":0.494549959897995},{"id":"https://openalex.org/C2776672577","wikidata":"https://www.wikidata.org/wiki/Q419618","display_name":"Deferoxamine","level":2,"score":0.45095860958099365},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.42922866344451904},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.23463022708892822},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.12371557950973511},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.07387286424636841},{"id":"https://openalex.org/C2776428424","wikidata":"https://www.wikidata.org/wiki/Q2602701","display_name":"Schiff base","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000145","qualifier_name":"classification","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D001547","descriptor_name":"Benzaldehydes","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001547","descriptor_name":"Benzaldehydes","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D002453","descriptor_name":"Cell Cycle","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002455","descriptor_name":"Cell Division","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003676","descriptor_name":"Deferoxamine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004354","descriptor_name":"Drug Screening Assays, Antitumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005293","descriptor_name":"Ferritins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006131","descriptor_name":"Growth Inhibitors","qualifier_ui":"Q000145","qualifier_name":"classification","is_major_topic":false},{"descriptor_ui":"D006131","descriptor_name":"Growth Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006131","descriptor_name":"Growth Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006835","descriptor_name":"Hydrazones","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006835","descriptor_name":"Hydrazones","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D007501","descriptor_name":"Iron","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D007502","descriptor_name":"Iron Chelating Agents","qualifier_ui":"Q000145","qualifier_name":"classification","is_major_topic":false},{"descriptor_ui":"D007502","descriptor_name":"Iron Chelating Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D007502","descriptor_name":"Iron Chelating Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D007538","descriptor_name":"Isoniazid","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D007538","descriptor_name":"Isoniazid","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007538","descriptor_name":"Isoniazid","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D008024","descriptor_name":"Ligands","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009284","descriptor_name":"Naphthols","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D009284","descriptor_name":"Naphthols","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D009363","descriptor_name":"Neoplasm Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D011730","descriptor_name":"Pyridoxal","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D011730","descriptor_name":"Pyridoxal","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011730","descriptor_name":"Pyridoxal","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014168","descriptor_name":"Transferrin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015195","descriptor_name":"Drug Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015394","descriptor_name":"Molecular Structure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D018922","descriptor_name":"HL-60 Cells","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D018922","descriptor_name":"HL-60 Cells","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018922","descriptor_name":"HL-60 Cells","qualifier_ui":"Q000648","qualifier_name":"ultrastructure","is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053938","descriptor_name":"DNA Fragmentation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1182/blood.v89.8.3025","doi":"https://doi.org/10.1182/blood.v89.8.3025","is_oa":true,"landing_page_url":"https://doi.org/10.1182/blood.v89.8.3025","pdf_url":"https://ashpublications.org/blood/article-pdf/89/8/3025/1038548/3025.pdf","source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},{"id":"pmid:9108424","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9108424","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"Comparative Study"}],"best_oa_location":{"id":"doi:10.1182/blood.v89.8.3025","doi":"https://doi.org/10.1182/blood.v89.8.3025","is_oa":true,"landing_page_url":"https://doi.org/10.1182/blood.v89.8.3025","pdf_url":"https://ashpublications.org/blood/article-pdf/89/8/3025/1038548/3025.pdf","source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320324195","display_name":"Medical Research Council Canada","ror":"https://ror.org/01gavpb45"},{"id":"https://openalex.org/F4320334626","display_name":"Medical Research Council","ror":"https://ror.org/03x94j517"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W34816746.pdf","grobid_xml":"https://content.openalex.org/works/W34816746.grobid-xml"},"referenced_works_count":45,"referenced_works":["https://openalex.org/W288628557","https://openalex.org/W295614617","https://openalex.org/W1497514444","https://openalex.org/W1502461041","https://openalex.org/W1510505825","https://openalex.org/W1526693931","https://openalex.org/W1564880933","https://openalex.org/W1575773639","https://openalex.org/W1589415602","https://openalex.org/W1630176173","https://openalex.org/W1649488331","https://openalex.org/W1871616831","https://openalex.org/W1892554314","https://openalex.org/W1966469827","https://openalex.org/W1968853836","https://openalex.org/W1970518172","https://openalex.org/W1991605327","https://openalex.org/W1992367787","https://openalex.org/W2025984741","https://openalex.org/W2033519619","https://openalex.org/W2035763080","https://openalex.org/W2041330974","https://openalex.org/W2045711003","https://openalex.org/W2050416300","https://openalex.org/W2051983330","https://openalex.org/W2067900214","https://openalex.org/W2080166898","https://openalex.org/W2080711791","https://openalex.org/W2084609653","https://openalex.org/W2104434601","https://openalex.org/W2112084291","https://openalex.org/W2116611374","https://openalex.org/W2119272726","https://openalex.org/W2138655599","https://openalex.org/W2159401034","https://openalex.org/W2169013600","https://openalex.org/W2223245761","https://openalex.org/W2400973399","https://openalex.org/W2401775420","https://openalex.org/W2414256411","https://openalex.org/W2417365885","https://openalex.org/W2913180427","https://openalex.org/W6636475692","https://openalex.org/W6845715508","https://openalex.org/W7074184880"],"related_works":["https://openalex.org/W1502461041","https://openalex.org/W1992367796","https://openalex.org/W2089027621","https://openalex.org/W2002176182","https://openalex.org/W116663061","https://openalex.org/W2034409947","https://openalex.org/W2065071495","https://openalex.org/W2080711791","https://openalex.org/W7009298523"],"abstract_inverted_index":{"We":[0],"have":[1],"recently":[2],"screened":[3],"36":[4],"analogues":[5,77,90,117],"of":[6,72,74,81,141,144,158,193,211,220,240,252,275],"the":[7,70,89,115,142,159,200,207,218,221,238,243,250,256,263,272],"lipophilic":[8],"iron":[9],"(Fe)":[10],"chelator,":[11],"pyridoxal":[12],"isonicotinoyl":[13],"hydrazone":[14,35,44],"(PIH),":[15],"for":[16,271],"their":[17],"antiproliferative":[18,52],"effect":[19,251],"(Richardson":[20],"et":[21],"al,":[22],"Blood":[23],"86:4295,":[24],"1995).":[25],"Of":[26],"these":[27,75,212,276],"compounds,":[28],"1":[29],"chelator":[30],"derived":[31,40],"from":[32,41,124,131,163],"salicylaldehyde":[33],"benzoyl":[34,43],"(206)":[36],"and":[37,48,101,104,127,178,188,234],"4":[38],"ligands":[39],"2-hydroxy-1-naphthylaldehyde":[42],"(308,":[45],"309,":[46],"311,":[47],"315)":[49],"showed":[50,87,109,155,216],"pronounced":[51],"activity,":[53],"being":[54,206],"far":[55,92],"more":[56,93],"effective":[57],"than":[58,95],"desferrioxamine":[59],"(DFO).":[60],"The":[61],"present":[62],"study":[63,267],"was":[64,165,189,259],"designed":[65],"to":[66,113],"investigate":[67],"in":[68,78,111,146,242,246],"detail":[69],"mechanism":[71],"action":[73],"PIH":[76,201],"a":[79],"variety":[80],"neoplastic":[82,147],"cell":[83,232,248,257,264],"lines.":[84],"This":[85,266],"investigation":[86],"that":[88,156,217],"were":[91,118,180,231],"active":[94],"DFO":[96,236],"at":[97,120,133,223],"inhibiting":[98],"cellular":[99],"proliferation":[100],"3H-thymidine,":[102],"3H-leucine,":[103],"3H-uridine":[105],"incorporation.":[106],"Additional":[107],"experiments":[108],"that,":[110],"contrast":[112],"DFO,":[114,197],"5":[116],"potent":[119],"preventing":[121],"59Fe":[122,129,145,160],"uptake":[123],"transferrin":[125],"(Tf)":[126],"increasing":[128],"release":[130],"cells":[132,148,195,241],"concentrations":[134],"as":[135,137,279],"low":[136],"10":[138],"micromol/L.":[139],"Examination":[140],"distribution":[143],"using":[149],"native":[150],"polyacrylamide":[151],"gel":[152],"electrophoresis":[153],"(PAGE)/59Fe-autoradiography":[154],"most":[157],"taken":[161],"up":[162],"Tf":[164],"incorporated":[166],"into":[167],"ferritin,":[168],"although":[169],"3":[170],"other":[171],"previously":[172],"unrecognized":[173],"components":[174],"(bands":[175],"A,":[176],"B,":[177],"C)":[179],"also":[181],"identified.":[182],"Band":[183],"C":[184],"comigrated":[185],"with":[186,196,203,227],"59Fe-citrate":[187],"chelated":[190],"on":[191,255,262],"incubation":[192],"neuroblastoma":[194],"PIH,":[198],"or":[199,229],"analogues,":[202],"this":[204],"compartment":[205],"main":[208],"intracellular":[209],"target":[210],"ligands.":[213],"Further":[214],"work":[215],"effects":[219],"chelators":[222,278],"inducing":[224],"characteristics":[225],"consistent":[226],"apoptosis":[228],"necrosis":[230],"line-specific,":[233],"while":[235],"increased":[237],"percentage":[239],"G0/G1":[244],"phases":[245],"all":[247],"types,":[249],"analogue":[253],"311":[254],"cycle":[258],"variable":[260],"depending":[261],"line.":[265],"provides":[268],"further":[269],"evidence":[270],"potential":[273],"use":[274],"Fe":[277],"anticancer":[280],"agents.":[281]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":8},{"year":2016,"cited_by_count":15},{"year":2015,"cited_by_count":8},{"year":2014,"cited_by_count":12},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":10}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
